24th Edition Strategic Project & Portfolio Management for Pharma 2024 | Marcus Evans Group | 23 January 2024 | London, UK

Join Our Marcus Evans Conference Where Leading Project and Portfolio Managers Discuss How They’re Supporting Critical Decision-making Capabilities Through Implementing the Best Methodologies, Technologies, and Organizational Models. We’ll Explore How You Can Maximize the Value and Resilience of Your Portfolio Through the Best Practices in Project Prioritization and Resource Allocation, Focusing on Creating the Ideal Balance Between Risks and Opportunities. We’ll Look at How Projects Can Be Planned and Managed More Effectively to Accelerate Delivery Times. Plus, We’ll Consider New Ways to Build Internal Capabilities and Ensure Alignment. You’ll Have the Opportunity to Discuss All These Topics and More in an Open and Engaging Environment, With Plenty of Networking and Brainstorming During the Interactive Sessions. At the End You’ll Walk Away With Actionable Insights on How to Build Effective Management Capabilities and Navigate Critical Decisions.

2023 Past Speakers

Tom Halliwell
Senior Vice President & Head of Operations, Ariceum Therapeutics, United Kingdom

Tobias Koshubs
Research Project Manager, Bayer, Germany

Tom Benedetto
Executive Director, R&D Capabilities, Bristol Myers Squibb, United States

Claire O'Brien
Senior Director, R&D Project Management, Cambrian Biopharma, United Kingdom

Audrey Robinson-Ballard
Associate Director, Pharmaceutical Project Management, Eli Lilly and Company, United States

Nathalie Mondoly
Director, Pharmaceutical Development Transformation and Enterprise Excellence Pharmaceutical Development – R&D, Ipsen, France

Simone Frandsen
Director R&D Portfolio and Strategy, LEO Pharma, Denmark

Dr. Thorsten Knoechel
Head of R&D Governance Operations, Merck, Germany

David Yee
Head, Portfolio Systems, Novartis, United States